Hepariny 2022

CzechTenders notice for Hepariny 2022. The reference ID of the tender is 74745590 and it is closing on 19 Dec 2022.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Hepariny 2022
  • CZT Ref No: 74745590
  • Deadline: 19 Dec 2022
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: Z2022-046887
  • Purchaser's Detail :
    Official name : Faculty Hospital Olomouc
    Company ID : 00098892
    mail address : i. P. Pavlova 185/6
    municipality : Olomouc
    Zip code : 77900
    Contact person : Ing. Pavel Dockal
    Phone :+420 588443138
    NUTS code : cz071
    e-mail : zapazky@fnol.cz
    Email :zakazky@fnol.cz
    URL :https//www.fnol.cz/

  • Description :
  • Hepariny 2022

    Description of the order: Pre -ahead of this part of the public customers are supplements of leaks with the contents of the orbits of heparin.

    VAT value: 69 822 991.00

    Currency: CZK

    Date of Publication in VVZ: 18.11.2022 21219

    Type: Dodavy

    Place of delivery: Faculty Hospital Olomouc
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CzechTenders Features

CzechTenders Features

Fresh and verified Tenders from Czech. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech in your email inbox.

  Chat with us